Pharmaloz

Pharmaloz is a private, revenue-generating CDMO and one of the largest lozenge manufacturers in the United States, operating from a 60,000+ sq. ft. FDA-compliant facility in Miami. The company offers end-to-end services including R&D, formulation, contract manufacturing, private label production, and marketing support for over-the-counter consumer healthcare products. Its business model is purely service-based, partnering with brokers, retailers, and brands to develop and manufacture products, with a core focus on lozenge delivery systems. Pharmaloz's established infrastructure, regulatory expertise, and commitment to quality position it as a key player in the contract manufacturing space for solid-dose consumer health products.

Integrated contract development and manufacturing platform specializing in lozenge formulation and production. Capabilities include proprietary blend development, flavor refinement, dose optimization, stabilization of challenging actives, and full-scale cGMP manufacturing under FDA guidelines.

Pharmaloz competes in the fragmented CDMO space, facing competition from large, diversified CDMOs (e.g., Catalent, Lonza) and smaller, niche manufacturers. Its primary differentiation is its specialized focus on lozenges and strong U.S. operational base. Competition is based on technical capability, quality, cost, speed, and regulatory track record.